Compile Data Set for Download or QSAR

Found 651 hits with Last Name = 'dehm' and Initial = 'f'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Histone deacetylase 6 (Homo sapiens (Human))	BDBM50252005 (2-(3-Benzoylamino-phenyl)-2-oxoethyl ethyl trithio...) Show SMILES CCSC(=S)SCC(=O)c1cccc(NC(=O)c2ccccc2)c1 Show InChI InChI=1S/C18H17NO2S3/c1-2-23-18(22)24-12-16(20)14-9-6-10-15(11-14)19-17(21)13-7-4-3-5-8-13/h3-11H,2,12H2,1H3,(H,19,21)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	110	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Nycomed GmbH Curated by ChEMBL					Assay Description Inhibition of recombinant HDAC6 (unknown origin) expressed in HEK293 cells using variable substrate concentration by Lineweaver-Burk plot				J Med Chem 51: 3985-4001 (2008) Article DOI: 10.1021/jm800093c BindingDB Entry DOI: 10.7270/Q29886S0
					More data for this Ligand-Target Pair
Histone deacetylase 6 (Homo sapiens (Human))	BDBM50252371 (CHEMBL520279 | Ethyl 2-oxo-2-[1-(phenyl-sulfonyl)-...) Show SMILES CCSC(=S)SCC(=O)c1ccn(c1)S(=O)(=O)c1ccccc1 Show InChI InChI=1S/C15H15NO3S4/c1-2-21-15(20)22-11-14(17)12-8-9-16(10-12)23(18,19)13-6-4-3-5-7-13/h3-10H,2,11H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	140	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Nycomed GmbH Curated by ChEMBL					Assay Description Inhibition of recombinant HDAC6 (unknown origin) expressed in HEK293 cells using variable substrate concentration by Lineweaver-Burk plot				J Med Chem 51: 3985-4001 (2008) Article DOI: 10.1021/jm800093c BindingDB Entry DOI: 10.7270/Q29886S0
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM50252319 (CHEMBL479602 | Ethyl 2-oxo-2-{5-[(2-Phenoxy-ethylc...) Show SMILES CCSC(=S)SCC(=O)c1ccc(CC(=O)NCCOc2ccccc2)s1 Show InChI InChI=1S/C19H21NO3S4/c1-2-25-19(24)26-13-16(21)17-9-8-15(27-17)12-18(22)20-10-11-23-14-6-4-3-5-7-14/h3-9H,2,10-13H2,1H3,(H,20,22)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	460	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Nycomed GmbH Curated by ChEMBL					Assay Description Inhibition of recombinant HDAC1 (unknown origin) expressed in HEK293 cells using variable substrate concentration by Lineweaver-Burk plot				J Med Chem 51: 3985-4001 (2008) Article DOI: 10.1021/jm800093c BindingDB Entry DOI: 10.7270/Q29886S0
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM50217137 (CHEMBL388710 | Ethyl 2-(4-Methylphenyl)-2-oxoethyl...) Show SMILES CCSC(=S)SCC(=O)c1ccc(C)cc1 Show InChI InChI=1S/C12H14OS3/c1-3-15-12(14)16-8-11(13)10-6-4-9(2)5-7-10/h4-7H,3,8H2,1-2H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	7.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Altana Pharma AG Curated by ChEMBL					Assay Description Inhibition of HDAC1 in HeLa cells				Bioorg Med Chem Lett 17: 4746-52 (2007) Article DOI: 10.1016/j.bmcl.2007.06.063 BindingDB Entry DOI: 10.7270/Q26H4H45
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM50217137 (CHEMBL388710 | Ethyl 2-(4-Methylphenyl)-2-oxoethyl...) Show SMILES CCSC(=S)SCC(=O)c1ccc(C)cc1 Show InChI InChI=1S/C12H14OS3/c1-3-15-12(14)16-8-11(13)10-6-4-9(2)5-7-10/h4-7H,3,8H2,1-2H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	7.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Nycomed GmbH Curated by ChEMBL					Assay Description Inhibition of recombinant HDAC1 (unknown origin) expressed in HEK293 cells using variable substrate concentration by Lineweaver-Burk plot				J Med Chem 51: 3985-4001 (2008) Article DOI: 10.1021/jm800093c BindingDB Entry DOI: 10.7270/Q29886S0
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145937 (US8957064, 57.0) Show SMILES Cc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4cccc(C)n4)cc3)c(cn2c1Br)-c1ccccc1 Show InChI InChI=1S/C31H27BrN8/c1-19-7-6-10-26(33-19)30-36-29(37-38-30)24-16-39(17-24)15-21-11-13-23(14-12-21)27-25(22-8-4-3-5-9-22)18-40-28(32)20(2)34-31(40)35-27/h3-14,18,24H,15-17H2,1-2H3,(H,36,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145934 (US8957064, 54.0) Show SMILES Cc1cccc(n1)-c1nc(n[nH]1)C1CCN(Cc2ccc(cc2)-c2nc3nccn3cc2-c2ccccc2F)CC1 Show InChI InChI=1S/C32H29FN8/c1-21-5-4-8-28(35-21)31-37-30(38-39-31)24-13-16-40(17-14-24)19-22-9-11-23(12-10-22)29-26(25-6-2-3-7-27(25)33)20-41-18-15-34-32(41)36-29/h2-12,15,18,20,24H,13-14,16-17,19H2,1H3,(H,37,38,39)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145958 (US8957064, 72.4) Show SMILES CSc1nc2nc(-c3ccc(CN4CCC(CC4)c4n[nH]c(n4)-c4cccc(C)n4)cc3)c(cn2n1)-c1ccccc1 Show InChI InChI=1S/C32H31N9S/c1-21-7-6-10-27(33-21)30-35-29(37-38-30)25-15-17-40(18-16-25)19-22-11-13-24(14-12-22)28-26(23-8-4-3-5-9-23)20-41-31(34-28)36-32(39-41)42-2/h3-14,20,25H,15-19H2,1-2H3,(H,35,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145889 (US8957064, 26.0) Show SMILES Cc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4ccccn4)cc3)c(cn2c1Br)-c1ccccc1 Show InChI InChI=1S/C30H25BrN8/c1-19-27(31)39-18-24(21-7-3-2-4-8-21)26(34-30(39)33-19)22-12-10-20(11-13-22)15-38-16-23(17-38)28-35-29(37-36-28)25-9-5-6-14-32-25/h2-14,18,23H,15-17H2,1H3,(H,35,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145953 (US8957064, 71.0) Show SMILES CSc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4cccc(C)n4)cc3)c(cn2n1)-c1ccccc1 Show InChI InChI=1S/C30H27N9S/c1-19-7-6-10-25(31-19)28-33-27(35-36-28)23-16-38(17-23)15-20-11-13-22(14-12-20)26-24(21-8-4-3-5-9-21)18-39-29(32-26)34-30(37-39)40-2/h3-14,18,23H,15-17H2,1-2H3,(H,33,35,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145872 (US8957064, 10.0 | US8957064, 36.0) Show SMILES C(N1CCC(CC1)c1cnc2ccccc2n1)c1ccc(cc1)-c1nc2nccn2cc1-c1ccccc1 Show InChI InChI=1S/C32H28N6/c1-2-6-24(7-3-1)27-22-38-19-16-33-32(38)36-31(27)26-12-10-23(11-13-26)21-37-17-14-25(15-18-37)30-20-34-28-8-4-5-9-29(28)35-30/h1-13,16,19-20,22,25H,14-15,17-18,21H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145889 (US8957064, 26.0) Show SMILES Cc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4ccccn4)cc3)c(cn2c1Br)-c1ccccc1 Show InChI InChI=1S/C30H25BrN8/c1-19-27(31)39-18-24(21-7-3-2-4-8-21)26(34-30(39)33-19)22-12-10-20(11-13-22)15-38-16-23(17-38)28-35-29(37-36-28)25-9-5-6-14-32-25/h2-14,18,23H,15-17H2,1H3,(H,35,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145920 (US8957064, 48.1) Show SMILES COC(=O)c1cnn2cc(c(nc12)-c1ccc(CN2CCC(CC2)c2n[nH]c(n2)-c2ccccn2)cc1)-c1c(F)cccc1F |(-11.96,4.7,;-11.56,3.21,;-10.07,2.81,;-8.98,3.9,;-9.67,1.32,;-10.58,.08,;-9.67,-1.17,;-8.21,-.69,;-6.88,-1.46,;-5.54,-.69,;-5.54,.85,;-6.88,1.62,;-8.21,.85,;-4.21,1.62,;-2.88,.85,;-1.54,1.62,;-1.54,3.16,;-.21,3.93,;1.13,3.16,;1.13,1.62,;2.46,.85,;3.79,1.62,;3.79,3.16,;2.46,3.93,;5.13,.85,;5.13,-.69,;6.59,-1.17,;7.5,.08,;6.59,1.32,;8.98,.47,;10.07,-.61,;11.56,-.22,;11.96,1.27,;10.87,2.36,;9.38,1.96,;-2.88,3.93,;-4.21,3.16,;-4.77,-2.03,;-5.54,-3.36,;-7.08,-3.36,;-4.77,-4.7,;-3.23,-4.7,;-2.46,-3.36,;-3.23,-2.03,;-2.46,-.69,)| Show InChI InChI=1S/C33H28F2N8O2/c1-45-33(44)23-17-37-43-19-24(28-25(34)5-4-6-26(28)35)29(38-32(23)43)21-10-8-20(9-11-21)18-42-15-12-22(13-16-42)30-39-31(41-40-30)27-7-2-3-14-36-27/h2-11,14,17,19,22H,12-13,15-16,18H2,1H3,(H,39,40,41)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145954 (US8957064, 72.0) Show SMILES CSc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4ccccn4)cc3)c(cn2n1)-c1ccccc1 Show InChI InChI=1S/C29H25N9S/c1-39-29-33-28-31-25(23(18-38(28)36-29)20-7-3-2-4-8-20)21-12-10-19(11-13-21)15-37-16-22(17-37)26-32-27(35-34-26)24-9-5-6-14-30-24/h2-14,18,22H,15-17H2,1H3,(H,32,34,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145952 (US8957064, 70.0) Show SMILES C(N1CC(C1)c1n[nH]c(n1)-c1ccccn1)c1ccc(cc1)-c1nc2nc(nn2cc1-c1ccccc1)C1CC1 Show InChI InChI=1S/C31H27N9/c1-2-6-21(7-3-1)25-19-40-31(35-29(38-40)23-13-14-23)33-27(25)22-11-9-20(10-12-22)16-39-17-24(18-39)28-34-30(37-36-28)26-8-4-5-15-32-26/h1-12,15,19,23-24H,13-14,16-18H2,(H,34,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145905 (US8957064, 42.0) Show SMILES CCc1cnn2cc(-c3ccccc3)c(nc12)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2cccc(C)n2)cc1 Show InChI InChI=1S/C32H30N8/c1-3-23-16-33-40-20-27(24-9-5-4-6-10-24)29(35-32(23)40)25-14-12-22(13-15-25)17-39-18-26(19-39)30-36-31(38-37-30)28-11-7-8-21(2)34-28/h4-16,20,26H,3,17-19H2,1-2H3,(H,36,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145953 (US8957064, 71.0) Show SMILES CSc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4cccc(C)n4)cc3)c(cn2n1)-c1ccccc1 Show InChI InChI=1S/C30H27N9S/c1-19-7-6-10-25(31-19)28-33-27(35-36-28)23-16-38(17-23)15-20-11-13-22(14-12-20)26-24(21-8-4-3-5-9-21)18-39-29(32-26)34-30(37-39)40-2/h3-14,18,23H,15-17H2,1-2H3,(H,33,35,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145958 (US8957064, 72.4) Show SMILES CSc1nc2nc(-c3ccc(CN4CCC(CC4)c4n[nH]c(n4)-c4cccc(C)n4)cc3)c(cn2n1)-c1ccccc1 Show InChI InChI=1S/C32H31N9S/c1-21-7-6-10-27(33-21)30-35-29(37-38-30)25-15-17-40(18-16-25)19-22-11-13-24(14-12-22)28-26(23-8-4-3-5-9-23)20-41-31(34-28)36-32(39-41)42-2/h3-14,20,25H,15-19H2,1-2H3,(H,35,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145867 (US8957064, 5.0) Show SMILES Clc1cnc2nc(-c3ccc(CN4CC(C4)c4nnc([nH]4)-c4ccccn4)cc3)c(cn12)-c1ccccc1 Show InChI InChI=1S/C29H23ClN8/c30-25-14-32-29-33-26(23(18-38(25)29)20-6-2-1-3-7-20)21-11-9-19(10-12-21)15-37-16-22(17-37)27-34-28(36-35-27)24-8-4-5-13-31-24/h1-14,18,22H,15-17H2,(H,34,35,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145935 (US8957064, 55.0) Show SMILES Brc1cnc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4ccccn4)cc3)c(cn12)-c1ccccc1 Show InChI InChI=1S/C29H23BrN8/c30-25-14-32-29-33-26(23(18-38(25)29)20-6-2-1-3-7-20)21-11-9-19(10-12-21)15-37-16-22(17-37)27-34-28(36-35-27)24-8-4-5-13-31-24/h1-14,18,22H,15-17H2,(H,34,35,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145937 (US8957064, 57.0) Show SMILES Cc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4cccc(C)n4)cc3)c(cn2c1Br)-c1ccccc1 Show InChI InChI=1S/C31H27BrN8/c1-19-7-6-10-26(33-19)30-36-29(37-38-30)24-16-39(17-24)15-21-11-13-23(14-12-21)27-25(22-8-4-3-5-9-22)18-40-28(32)20(2)34-31(40)35-27/h3-14,18,24H,15-17H2,1-2H3,(H,36,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145932 (US8957064, 53.0) Show SMILES Cc1cccc(n1)-c1nc(n[nH]1)C1CCN(Cc2ccc(cc2)-c2nc3ncc(Br)n3cc2-c2ccc(F)cc2)CC1 Show InChI InChI=1S/C32H28BrFN8/c1-20-3-2-4-27(36-20)31-38-30(39-40-31)24-13-15-41(16-14-24)18-21-5-7-23(8-6-21)29-26(22-9-11-25(34)12-10-22)19-42-28(33)17-35-32(42)37-29/h2-12,17,19,24H,13-16,18H2,1H3,(H,38,39,40)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145888 (US8957064, 25.0) Show SMILES Cc1cnc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4cccc(C)n4)cc3)c(cn12)-c1ccccc1 Show InChI InChI=1S/C31H28N8/c1-20-7-6-10-27(33-20)30-35-29(36-37-30)25-17-38(18-25)16-22-11-13-24(14-12-22)28-26(23-8-4-3-5-9-23)19-39-21(2)15-32-31(39)34-28/h3-15,19,25H,16-18H2,1-2H3,(H,35,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145895 (US8957064, 32.0) Show SMILES COC(=O)c1cnn2cc(-c3ccc(F)cc3F)c(nc12)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2ccccn2)cc1 Show InChI InChI=1S/C31H24F2N8O2/c1-43-31(42)23-13-35-41-17-24(22-10-9-21(32)12-25(22)33)27(36-30(23)41)19-7-5-18(6-8-19)14-40-15-20(16-40)28-37-29(39-38-28)26-4-2-3-11-34-26/h2-13,17,20H,14-16H2,1H3,(H,37,38,39)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145909 (US8957064, 44.0) Show SMILES Cc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4ccccn4)cc3)c(-c3ccccc3)c(C)n2n1 Show InChI InChI=1S/C30H27N9/c1-19-26(22-8-4-3-5-9-22)27(33-30-32-20(2)37-39(19)30)23-13-11-21(12-14-23)16-38-17-24(18-38)28-34-29(36-35-28)25-10-6-7-15-31-25/h3-15,24H,16-18H2,1-2H3,(H,34,35,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145919 (US8957064, 48.0) Show SMILES COC(=O)c1cnn2cc(c(nc12)-c1ccc(CN2CCC(CC2)c2n[nH]c(n2)-c2cccc(C)n2)cc1)-c1c(F)cccc1F |(-11.96,4.7,;-11.56,3.21,;-10.07,2.81,;-8.98,3.9,;-9.67,1.32,;-10.58,.08,;-9.67,-1.17,;-8.21,-.69,;-6.88,-1.46,;-5.54,-.69,;-5.54,.85,;-6.88,1.62,;-8.21,.85,;-4.21,1.62,;-2.88,.85,;-1.54,1.62,;-1.54,3.16,;-.21,3.93,;1.13,3.16,;1.13,1.62,;2.46,.85,;3.79,1.62,;3.79,3.16,;2.46,3.93,;5.13,.85,;5.13,-.69,;6.59,-1.17,;7.5,.08,;6.59,1.32,;8.98,.47,;10.07,-.61,;11.56,-.22,;11.96,1.27,;10.87,2.36,;11.27,3.85,;9.38,1.96,;-2.88,3.93,;-4.21,3.16,;-4.77,-2.03,;-5.54,-3.36,;-7.08,-3.36,;-4.77,-4.7,;-3.23,-4.7,;-2.46,-3.36,;-3.23,-2.03,;-2.46,-.69,)| Show InChI InChI=1S/C34H30F2N8O2/c1-20-5-3-8-28(38-20)32-40-31(41-42-32)23-13-15-43(16-14-23)18-21-9-11-22(12-10-21)30-25(29-26(35)6-4-7-27(29)36)19-44-33(39-30)24(17-37-44)34(45)46-2/h3-12,17,19,23H,13-16,18H2,1-2H3,(H,40,41,42)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145952 (US8957064, 70.0) Show SMILES C(N1CC(C1)c1n[nH]c(n1)-c1ccccn1)c1ccc(cc1)-c1nc2nc(nn2cc1-c1ccccc1)C1CC1 Show InChI InChI=1S/C31H27N9/c1-2-6-21(7-3-1)25-19-40-31(35-29(38-40)23-13-14-23)33-27(25)22-11-9-20(10-12-22)16-39-17-24(18-39)28-34-30(37-36-28)26-8-4-5-15-32-26/h1-12,15,19,23-24H,13-14,16-18H2,(H,34,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145955 (US8957064, 72.1) Show SMILES CSc1nc2nc(-c3ccc(CN4CCC(CC4)c4n[nH]c(n4)-c4ccccn4)cc3)c(cn2n1)-c1ccccc1 Show InChI InChI=1S/C31H29N9S/c1-41-31-35-30-33-27(25(20-40(30)38-31)22-7-3-2-4-8-22)23-12-10-21(11-13-23)19-39-17-14-24(15-18-39)28-34-29(37-36-28)26-9-5-6-16-32-26/h2-13,16,20,24H,14-15,17-19H2,1H3,(H,34,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145943 (US8957064, 63.1) Show SMILES COc1nn2cc(c(nc2c1CO)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2cccc(C)n2)cc1)-c1c(F)cccc1F |(-12.03,-1.23,;-11.26,.11,;-9.72,.11,;-8.82,-1.14,;-7.35,-.66,;-6.02,-1.43,;-4.69,-.66,;-4.69,.88,;-6.02,1.65,;-7.35,.88,;-8.82,1.35,;-9.22,2.84,;-10.7,3.24,;-3.35,1.65,;-2.02,.88,;-.69,1.65,;-.69,3.19,;.65,3.96,;1.98,3.19,;2.38,1.7,;3.87,2.1,;3.47,3.58,;5.2,1.33,;5.2,-.21,;6.67,-.69,;7.57,.56,;6.67,1.8,;9.06,.96,;10.15,-.13,;11.64,.27,;12.03,1.75,;10.95,2.84,;11.34,4.33,;9.46,2.44,;-2.02,3.96,;-3.35,3.19,;-3.6,-1.75,;-4,-3.24,;-5.48,-3.64,;-2.91,-4.33,;-1.42,-3.93,;-1.02,-2.44,;-2.11,-1.35,;-1.71,.13,)| Show InChI InChI=1S/C32H28F2N8O2/c1-18-5-3-8-26(35-18)30-37-29(38-39-30)21-14-41(15-21)13-19-9-11-20(12-10-19)28-22(27-24(33)6-4-7-25(27)34)16-42-31(36-28)23(17-43)32(40-42)44-2/h3-12,16,21,43H,13-15,17H2,1-2H3,(H,37,38,39)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145910 (US8957064, 44.1) Show SMILES Cc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4cccc(C)n4)cc3)c(-c3ccccc3)c(C)n2n1 Show InChI InChI=1S/C31H29N9/c1-19-8-7-11-26(32-19)30-35-29(36-37-30)25-17-39(18-25)16-22-12-14-24(15-13-22)28-27(23-9-5-4-6-10-23)20(2)40-31(34-28)33-21(3)38-40/h4-15,25H,16-18H2,1-3H3,(H,35,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145930 (US8957064, 52.1) Show SMILES Fc1ccc(cc1)-c1cn2ccnc2nc1-c1ccc(CN2CCC(CC2)c2n[nH]c(n2)-c2ccccn2)cc1 Show InChI InChI=1S/C31H27FN8/c32-25-10-8-22(9-11-25)26-20-40-18-15-34-31(40)35-28(26)23-6-4-21(5-7-23)19-39-16-12-24(13-17-39)29-36-30(38-37-29)27-3-1-2-14-33-27/h1-11,14-15,18,20,24H,12-13,16-17,19H2,(H,36,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145872 (US8957064, 10.0 | US8957064, 36.0) Show SMILES C(N1CCC(CC1)c1cnc2ccccc2n1)c1ccc(cc1)-c1nc2nccn2cc1-c1ccccc1 Show InChI InChI=1S/C32H28N6/c1-2-6-24(7-3-1)27-22-38-19-16-33-32(38)36-31(27)26-12-10-23(11-13-26)21-37-17-14-25(15-18-37)30-20-34-28-8-4-5-9-29(28)35-30/h1-13,16,19-20,22,25H,14-15,17-18,21H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145913 (US8957064, 45.2) Show SMILES CC(C)Nc1c(-c2ccccc2)c(nc2nc(C)nn12)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2ccccn2)cc1 Show InChI InChI=1S/C32H32N10/c1-20(2)34-31-27(23-9-5-4-6-10-23)28(36-32-35-21(3)40-42(31)32)24-14-12-22(13-15-24)17-41-18-25(19-41)29-37-30(39-38-29)26-11-7-8-16-33-26/h4-16,20,25,34H,17-19H2,1-3H3,(H,37,38,39)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145929 (US8957064, 52.0) Show SMILES Cc1cccc(n1)-c1nc(n[nH]1)C1CCN(Cc2ccc(cc2)-c2nc3nccn3cc2-c2ccc(F)cc2)CC1 Show InChI InChI=1S/C32H29FN8/c1-21-3-2-4-28(35-21)31-37-30(38-39-31)25-13-16-40(17-14-25)19-22-5-7-24(8-6-22)29-27(23-9-11-26(33)12-10-23)20-41-18-15-34-32(41)36-29/h2-12,15,18,20,25H,13-14,16-17,19H2,1H3,(H,37,38,39)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145904 (US8957064, 41.0) Show SMILES Cc1cccc(n1)-c1nc(n[nH]1)C1CN(Cc2ccc(cc2)-c2nc3nc(nn3cc2-c2ccccc2)C2CC2)C1 Show InChI InChI=1S/C32H29N9/c1-20-6-5-9-27(33-20)31-35-29(37-38-31)25-17-40(18-25)16-21-10-12-23(13-11-21)28-26(22-7-3-2-4-8-22)19-41-32(34-28)36-30(39-41)24-14-15-24/h2-13,19,24-25H,14-18H2,1H3,(H,35,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145936 (US8957064, 56.0) Show SMILES Cc1cn2cc(-c3ccccc3)c(nc2n1)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2ccccn2)cc1 Show InChI InChI=1S/C30H26N8/c1-20-15-38-19-25(22-7-3-2-4-8-22)27(33-30(38)32-20)23-12-10-21(11-13-23)16-37-17-24(18-37)28-34-29(36-35-28)26-9-5-6-14-31-26/h2-15,19,24H,16-18H2,1H3,(H,34,35,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145904 (US8957064, 41.0) Show SMILES Cc1cccc(n1)-c1nc(n[nH]1)C1CN(Cc2ccc(cc2)-c2nc3nc(nn3cc2-c2ccccc2)C2CC2)C1 Show InChI InChI=1S/C32H29N9/c1-20-6-5-9-27(33-20)31-35-29(37-38-31)25-17-40(18-25)16-21-10-12-23(13-11-21)28-26(22-7-3-2-4-8-22)19-41-32(34-28)36-30(39-41)24-14-15-24/h2-13,19,24-25H,14-18H2,1H3,(H,35,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145910 (US8957064, 44.1) Show SMILES Cc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4cccc(C)n4)cc3)c(-c3ccccc3)c(C)n2n1 Show InChI InChI=1S/C31H29N9/c1-19-8-7-11-26(32-19)30-35-29(36-37-30)25-17-39(18-25)16-22-12-14-24(15-13-22)28-27(23-9-5-4-6-10-23)20(2)40-31(34-28)33-21(3)38-40/h4-15,25H,16-18H2,1-3H3,(H,35,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145945 (US8957064, 63.3) Show SMILES COc1nn2cc(c(nc2c1CO)-c1ccc(CN2CCC(CC2)c2n[nH]c(n2)-c2ccccn2)cc1)-c1c(F)cccc1F |(-12.42,-1.04,;-11.65,.29,;-10.11,.29,;-9.21,-.95,;-7.74,-.48,;-6.41,-1.25,;-5.08,-.48,;-5.08,1.06,;-6.41,1.83,;-7.74,1.06,;-9.21,1.54,;-9.61,3.03,;-11.1,3.42,;-3.74,1.83,;-2.41,1.06,;-1.08,1.83,;-1.08,3.37,;.26,4.14,;1.59,3.37,;1.59,1.83,;2.92,1.06,;4.26,1.83,;4.26,3.37,;2.92,4.14,;5.59,1.06,;5.59,-.48,;7.06,-.95,;7.96,.29,;7.06,1.54,;9.45,.69,;10.54,-.4,;12.03,0,;12.42,1.49,;11.34,2.58,;9.85,2.18,;-2.41,4.14,;-3.74,3.37,;-3.99,-1.57,;-4.39,-3.05,;-5.87,-3.45,;-3.3,-4.14,;-1.81,-3.74,;-1.41,-2.26,;-2.5,-1.17,;-2.1,.32,)| Show InChI InChI=1S/C33H30F2N8O2/c1-45-33-24(19-44)32-37-29(23(18-43(32)41-33)28-25(34)5-4-6-26(28)35)21-10-8-20(9-11-21)17-42-15-12-22(13-16-42)30-38-31(40-39-30)27-7-2-3-14-36-27/h2-11,14,18,22,44H,12-13,15-17,19H2,1H3,(H,38,39,40)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145962 (US8957064, 74.1) Show SMILES COC(=O)c1cn2cc(-c3ccccc3)c(nc2n1)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2ccccn2)cc1 Show InChI InChI=1S/C31H26N8O2/c1-41-30(40)26-19-39-18-24(21-7-3-2-4-8-21)27(34-31(39)33-26)22-12-10-20(11-13-22)15-38-16-23(17-38)28-35-29(37-36-28)25-9-5-6-14-32-25/h2-14,18-19,23H,15-17H2,1H3,(H,35,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145941 (US8957064, 61.0) Show SMILES CNc1c(-c2ccccc2)c(nc2nc(C)cn12)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2cccc(C)n2)cc1 Show InChI InChI=1S/C32H31N9/c1-20-8-7-11-26(34-20)30-37-29(38-39-30)25-18-40(19-25)17-22-12-14-24(15-13-22)28-27(23-9-5-4-6-10-23)31(33-3)41-16-21(2)35-32(41)36-28/h4-16,25,33H,17-19H2,1-3H3,(H,37,38,39)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145867 (US8957064, 5.0) Show SMILES Clc1cnc2nc(-c3ccc(CN4CC(C4)c4nnc([nH]4)-c4ccccn4)cc3)c(cn12)-c1ccccc1 Show InChI InChI=1S/C29H23ClN8/c30-25-14-32-29-33-26(23(18-38(25)29)20-6-2-1-3-7-20)21-11-9-19(10-12-21)15-37-16-22(17-37)27-34-28(36-35-27)24-8-4-5-13-31-24/h1-14,18,22H,15-17H2,(H,34,35,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145908 (US8957064, 43.1) Show SMILES CC(C)Nc1nc2nc(-c3ccc(CN4CC(C4)c4n[nH]c(n4)-c4ccccn4)cc3)c(cn2n1)-c1ccccc1 Show InChI InChI=1S/C31H30N10/c1-20(2)33-30-36-31-34-27(25(19-41(31)39-30)22-8-4-3-5-9-22)23-13-11-21(12-14-23)16-40-17-24(18-40)28-35-29(38-37-28)26-10-6-7-15-32-26/h3-15,19-20,24H,16-18H2,1-2H3,(H,33,39)(H,35,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145912 (US8957064, 45.1) Show SMILES CNc1c(-c2ccccc2)c(nc2nc(C)nn12)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2cccc(C)n2)cc1 Show InChI InChI=1S/C31H30N10/c1-19-8-7-11-25(33-19)29-36-28(37-38-29)24-17-40(18-24)16-21-12-14-23(15-13-21)27-26(22-9-5-4-6-10-22)30(32-3)41-31(35-27)34-20(2)39-41/h4-15,24,32H,16-18H2,1-3H3,(H,36,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145932 (US8957064, 53.0) Show SMILES Cc1cccc(n1)-c1nc(n[nH]1)C1CCN(Cc2ccc(cc2)-c2nc3ncc(Br)n3cc2-c2ccc(F)cc2)CC1 Show InChI InChI=1S/C32H28BrFN8/c1-20-3-2-4-27(36-20)31-38-30(39-40-31)24-13-15-41(16-14-24)18-21-5-7-23(8-6-21)29-26(22-9-11-25(34)12-10-22)19-42-28(33)17-35-32(42)37-29/h2-12,17,19,24H,13-16,18H2,1H3,(H,38,39,40)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-beta serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145955 (US8957064, 72.1) Show SMILES CSc1nc2nc(-c3ccc(CN4CCC(CC4)c4n[nH]c(n4)-c4ccccn4)cc3)c(cn2n1)-c1ccccc1 Show InChI InChI=1S/C31H29N9S/c1-41-31-35-30-33-27(25(20-40(30)38-31)22-7-3-2-4-8-22)23-12-10-21(11-13-23)19-39-17-14-24(15-18-39)28-34-29(37-36-28)26-9-5-6-16-32-26/h2-13,16,20,24H,14-15,17-19H2,1H3,(H,34,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragrap...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145890 (US8957064, 27.0) Show SMILES COC(=O)c1cnn2cc(c(nc12)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2cccc(C)n2)cc1)-c1c(F)cccc1F |(-11.65,4.7,;-11.25,3.21,;-9.76,2.81,;-8.67,3.9,;-9.36,1.32,;-10.27,.08,;-9.36,-1.17,;-7.9,-.69,;-6.56,-1.46,;-5.23,-.69,;-5.23,.85,;-6.56,1.62,;-7.9,.85,;-3.9,1.62,;-2.56,.85,;-1.23,1.62,;-1.23,3.16,;.1,3.93,;1.44,3.16,;1.84,1.67,;3.32,2.07,;2.93,3.55,;4.66,1.3,;4.66,-.24,;6.12,-.72,;7.03,.53,;6.12,1.77,;8.57,.53,;9.34,-.81,;10.88,-.81,;11.65,.53,;10.88,1.86,;11.65,3.19,;9.34,1.86,;-2.56,3.93,;-3.9,3.16,;-4.46,-2.03,;-5.23,-3.36,;-6.77,-3.36,;-4.46,-4.7,;-2.92,-4.7,;-2.15,-3.36,;-2.92,-2.03,;-2.15,-.69,)| Show InChI InChI=1S/C32H26F2N8O2/c1-18-5-3-8-26(36-18)30-38-29(39-40-30)21-15-41(16-21)14-19-9-11-20(12-10-19)28-23(27-24(33)6-4-7-25(27)34)17-42-31(37-28)22(13-35-42)32(43)44-2/h3-13,17,21H,14-16H2,1-2H3,(H,38,39,40)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145961 (US8957064, 74.0) Show SMILES COC(=O)c1cn2cc(-c3ccccc3)c(nc2n1)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2cccc(C)n2)cc1 Show InChI InChI=1S/C32H28N8O2/c1-20-7-6-10-26(33-20)30-36-29(37-38-30)24-16-39(17-24)15-21-11-13-23(14-12-21)28-25(22-8-4-3-5-9-22)18-40-19-27(31(41)42-2)34-32(40)35-28/h3-14,18-19,24H,15-17H2,1-2H3,(H,36,37,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145901 (US8957064, 38.0) Show SMILES Cc1cn2cc(-c3ccccc3)c(nc2n1)-c1ccc(CN2CC(C2)c2n[nH]c(n2)-c2cccc(C)n2)cc1 Show InChI InChI=1S/C31H28N8/c1-20-7-6-10-27(32-20)30-35-29(36-37-30)25-17-38(18-25)16-22-11-13-24(14-12-22)28-26(23-8-4-3-5-9-23)19-39-15-21(2)33-31(39)34-28/h3-15,19,25H,16-18H2,1-2H3,(H,35,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM145921 (US8957064, 49.0) Show SMILES Cc1nc2nc(-c3ccc(CN4CCC(CC4)c4n[nH]c(n4)-c4cccc(C)n4)cc3)c(cn2n1)-c1cccc(F)c1 Show InChI InChI=1S/C32H30FN9/c1-20-5-3-8-28(34-20)31-37-30(38-39-31)24-13-15-41(16-14-24)18-22-9-11-23(12-10-22)29-27(25-6-4-7-26(33)17-25)19-42-32(36-29)35-21(2)40-42/h3-12,17,19,24H,13-16,18H2,1-2H3,(H,37,38,39)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	7.5	n/a
Bayer Intellectual Property GmbH US Patent					Assay Description Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following para...				US Patent US8957064 (2015) BindingDB Entry DOI: 10.7270/Q2Z60MRP
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 651 total )  |  Next  |  Last  >>

Jump to: